Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000895421-25-000494·Beta Bionics, Inc.
Schedule 13G ownership disclosure
Beta Bionics Inc
Common Stock · CUSIP: 08659B102
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Morgan Stanley
Shares: 2,928,838 · Class: 6.8%
- Morgan Stanley Capital Services LLC
Shares: 2,899,502 · Class: 6.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000895421-25-000494
- Form type
- SCHEDULE 13G
- Filer
- Beta Bionics, Inc.
- CIK
- CIK 1674632
- Filed
- Aug 07, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership